| Business Summary | | Diagnostic
Products
Corporation
develops,
manufactures
and
markets
medical
immunodiagnostic
test
kits
that
utilize
technology
derived
from
immunology
and
molecular
biology
and
automated
laboratory
instruments
that
perform
the
tests.
The
Company's
products
are
used
by
hospital,
clinical,
veterinary,
research
and
forensic
laboratories,
as
well
as
doctors'
offices,
to
obtain
precise
and
rapid
identification
and
measurement
of
hormones,
drugs,
viruses,
bacteria
and
other
substances
present
in
body
fluids
and
tissues
at
infinitesimal
concentrations.
The
principal
clinical
applications
of
the
Company's
more
than
400
assays
(tests)
relate
to
the
diagnosis
and
management
of
thyroid
disorders,
anemia,
reproductive
disorders,
diabetes,
allergies,
bone
metabolism,
infectious
diseases,
substance
abuse
and
certain
types
of
cancer.
The
Company's
kits
are
used
for
in
vitro
testing,
meaning
the
tests
are
performed
outside
of
the
body,
typically
in
a
test
tube. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | DP
develops,
manufactures
and
markets
medical
immunodiagnostic
test
kits
which
utilize
state-of-the-art
technology
derived
from
immunology
and
molecular
biology,
and
automated
laboratory
instruments.
For
the
six
months
ended
6/30/01,
revenues
rose
14%
to
$140.6
million.
Net
income
rose
39%
to
$18.6
million.
Revenues
reflect
a
higher
volume
of
IMMULITE
products
shipped
and
sold.
Net
income
reflects
increased
gross
margins
driven
by
manufacturing
efficiencies. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Michael Ziering, 44 Chairman,
CEO | $486K | Sidney Aroesty, 54 Sr.
VP, COO, Director | 318K | Said Shami, 58 Sr.
VP of R&D and CSO | 354K | James Brill, 49 VP-Fin. | 262K | Kathy Maugh, 56 VP
- Technical Operations | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|